Gallagher Carol Giltner 4
4 · Atara Biotherapeutics, Inc. · Filed Nov 15, 2023
Insider Transaction Report
Form 4
Gallagher Carol Giltner
Director
Transactions
- Purchase
Common Stock
2023-11-13$0.22/sh+179,020$40,029→ 368,438 total - Purchase
Common Stock
2023-11-14$0.31/sh+90,980$28,186→ 459,418 total
Footnotes (2)
- [F1]Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.205 to $0.251. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.
- [F2]Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2862 to $0.3229.